Get started
Author

Ibrahim Mohammed Hepishy

ORCID: 0009-0006-2175-3409
Observed ORCID: 0009-0006-2175-3409
OpenAlex ID: A5124884756
Targeting the GSK-3β/mTOR axis: a novel pharmacological strategy for preeclampsia prevention and treatment
2026 · Ahmed Baker A. Alshaikh, Hayder M. Al-kuraishy, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1
Fourth-generation allosteric EGFR inhibitors: Structure-based scaffold analysis and SAR exploration
2026 · Ibrahim Mohammed Hepishy, Mo'men Salem, et al. · Bioorganic Chemistry
Design, Synthesis, Biological Evaluation, and DFT Calculations of Indole 3-Acetic Acid Derivatives as Antimicrobial Agents.
2026 · Ahmed S. Nasr, Ibrahim Mohammed Hepishy, et al. · SINAI International Scientific Journal.
Activity Modulation of Quercetin by Semisynthetic Derivatives as VEGFR-2 Inhibitors, Antimicrobial and Antifungal: Design, Semi-Synthesis, Biological and Computational Studies
2026 · Mohamed Ahmed Abd El-Moneim, Mohamed Ahmed Mahmoud Abdel Reheim, et al. · Egyptian Journal of Chemistry
Benzimidazole-derived VEGFR-2 inhibitors: Docking, ADMET, anticancer evaluations, design and synthesis
2026 · Ibrahim Mohammed Hepishy, Helmy Sakr, et al. · Journal of Molecular Structure
Works count: 5
Citation count: 1
H-index: 1
I10-index:
Year
Topic
Type